On the present state of therapeutics PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download On the present state of therapeutics PDF full book. Access full book title On the present state of therapeutics by James Rogers. Download full books in PDF and EPUB format.
Author: James Rogers
Publisher:
ISBN:
Category :
Languages : en
Pages : 260
Get Book Here
Book Description
Author: James Rogers
Publisher:
ISBN:
Category :
Languages : en
Pages : 260
Get Book Here
Book Description
Author: James L. Nolan Jr.
Publisher: NYU Press
ISBN: 081475791X
Category : Political Science
Languages : en
Pages : 409
Get Book Here
Book Description
An analysis of the commingling of the therapeutic and political cultures in America. Nolan (anthropology and sociology, Williams College) supplies his background by looking at trends such as the emotivist ethic, the pathologization of human behavior, the rise of a new priestly class, and the legiti.
Author: Thomas Szasz
Publisher: Promtheus
ISBN: 9780879752422
Category : Psychology
Languages : en
Pages : 0
Get Book Here
Book Description
Chiefly reprints of articles originally published 1965-1983. Includes bibliographies and index.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309262054
Category : Medical
Languages : en
Pages : 159
Get Book Here
Book Description
In 1996, the Institute of Medicine (IOM) released its report Telemedicine: A Guide to Assessing Telecommunications for Health Care. In that report, the IOM Committee on Evaluating Clinical Applications of Telemedicine found telemedicine is similar in most respects to other technologies for which better evidence of effectiveness is also being demanded. Telemedicine, however, has some special characteristics-shared with information technologies generally-that warrant particular notice from evaluators and decision makers. Since that time, attention to telehealth has continued to grow in both the public and private sectors. Peer-reviewed journals and professional societies are devoted to telehealth, the federal government provides grant funding to promote the use of telehealth, and the private technology industry continues to develop new applications for telehealth. However, barriers remain to the use of telehealth modalities, including issues related to reimbursement, licensure, workforce, and costs. Also, some areas of telehealth have developed a stronger evidence base than others. The Health Resources and Service Administration (HRSA) sponsored the IOM in holding a workshop in Washington, DC, on August 8-9 2012, to examine how the use of telehealth technology can fit into the U.S. health care system. HRSA asked the IOM to focus on the potential for telehealth to serve geographically isolated individuals and extend the reach of scarce resources while also emphasizing the quality and value in the delivery of health care services. This workshop summary discusses the evolution of telehealth since 1996, including the increasing role of the private sector, policies that have promoted or delayed the use of telehealth, and consumer acceptance of telehealth. The Role of Telehealth in an Evolving Health Care Environment: Workshop Summary discusses the current evidence base for telehealth, including available data and gaps in data; discuss how technological developments, including mobile telehealth, electronic intensive care units, remote monitoring, social networking, and wearable devices, in conjunction with the push for electronic health records, is changing the delivery of health care in rural and urban environments. This report also summarizes actions that the U.S. Department of Health and Human Services (HHS) can undertake to further the use of telehealth to improve health care outcomes while controlling costs in the current health care environment.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309453070
Category : Science
Languages : en
Pages : 487
Get Book Here
Book Description
Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.
Author: Harry M. Marks
Publisher: Cambridge University Press
ISBN: 9780521785617
Category : Medical
Languages : en
Pages : 276
Get Book Here
Book Description
Explores the origins of contemporary drug regulation and the modern clinical trial.
Author: British Medical Association
Publisher: CRC Press
ISBN: 1000159655
Category : Medical
Languages : en
Pages : 160
Get Book Here
Book Description
At the last Annual Representative Meeting of the British Medical Association a motion was passed that `certain additional cannabinoids should be legalized for wider medicinal use.'' This report supports this landmark statement by reviewing the scientific evidence for the therapeutic use of cannabinoids and sets the agenda for change. It will be welcomed by those who believe that cannabinoids can be used in medical treatment. The report discusses in a clear and readable form the use and adverse effects of the drug for nausea, multiple sclerosis, pain, epilepsy, glaucoma, and asthma.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309158060
Category : Medical
Languages : en
Pages : 442
Get Book Here
Book Description
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Author: Brian Speer
Publisher: Elsevier Health Sciences
ISBN: 1455746711
Category : Medical
Languages : en
Pages : 929
Get Book Here
Book Description
A current and cutting-edge reference, Current Therapy in Avian Medicine and Surgery takes the popular Current Therapy approach in providing succinct and clear information pertinent to the medical care of avian species. Most chapters include an up-to-date delivery of the current state of knowledge on their subject material, and provide practical approaches and thought processes applicable to diagnosis and therapy where appropriate. Information is always easy to find, with topics including the latest advances in internal medicine; behavioral medicine; anesthesia, analgesia, and surgery. Sections dedicated to welfare, conservation, and practice risk management explore important, but less commonly discussed aspects of avian practice; and the pattern recognition portion of the text offers readers a view of what companion bird conditions are likely to be seen in practice in different parts of the world. Written by a team of highly regarded contributors from around the world, this text helps readers, regardless of location and current knowledge, develop and augment skills in the medical and surgical care of avian species. The Current Therapy format provides current, up-to-date, succinct and clear information pertinent to the medical and surgical care of avian species. Coverage of clinically significant topics includes current veterinary scientific literature and hot topics relating to today's avian medicine and surgery. Coverage of a wide variety of bird species includes psittacines, pigeons, raptors, ratites, waterfowl, gallinaceous birds, and less common species. More than 800 full-color images show avian disease, management strategies and thought processes, and aid in formulating guidelines to care. World-renowned, expert contributors provide cutting-edge information, offering authoritative, accurate, and sometimes controversial opinions in many areas of study. Summary tables simplify the lookup of key facts and treatment guidelines. References in each chapter facilitate further reading and research on specific topics.
Author: William R Strohl
Publisher: Elsevier
ISBN: 1908818093
Category : Medical
Languages : en
Pages : 697
Get Book Here
Book Description
The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas. Therapeutic antibody engineering examines all aspects of engineering monoclonal antibodies and analyses the effect that various genetic engineering approaches will have on future candidates. Chapters in the first part of the book provide an introduction to monoclonal antibodies, their discovery and development and the fundamental technologies used in their production. Following chapters cover a number of specific issues relating to different aspects of antibody engineering, including variable chain engineering, targets and mechanisms of action, classes of antibody and the use of antibody fragments, among many other topics. The last part of the book examines development issues, the interaction of human IgGs with non-human systems, and cell line development, before a conclusion looking at future issues affecting the field of therapeutic antibody engineering. - Goes beyond the standard engineering issues covered by most books and delves into structure-function relationships - Integration of knowledge across all areas of antibody engineering, development, and marketing - Discusses how current and future genetic engineering of cell lines will pave the way for much higher productivity
